.png){kind=icon}
.png){kind=icon}
Return
Cell-specific drug targeting in the lung
.png){kind=icon}
PRE
AI
DOI：10.1016/j.bcp.2021.114577.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Non-targeted drug delivery systems have several limitations including the decreased bioavailability of the drug, poor stability and rapid clearance in addition to off-target distribution. Cell-specific targeted delivery approaches promise to overcome some of these limitations and enhance therapeutic selectivity. In this review, we aim to discuss cell-specific targeted approaches in the lung at the biochemical and molecular levels. These approaches include; a) directly administered small molecule drugs with intracellular action; b) targeted biologics and synthetic hybrids with extracellular action; c) site activated drugs; and d) delivery systems. We discuss the pharmaceutical and biochemical parameters that govern the fate of drug molecules at delivery sites while presenting an overview of relevant literature surrounding this area of research and current advancements.
Keywords:
Cell-specific
Drug targeting
Lung
Nanocarriers
Drug release
Immunotherapy
Biopolymers
Site activated drugs
Pharmacokinetics